Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine S75:R25 vs Bupivacaine in Spinal Anesthesia
NCT01994967Phase 3Withdrawn
- Sponsor
- Cristália
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levobupivacaine in pain (2 arms), sponsored by Cristália. Primary endpoints: Time of latency to achieve sensitive block of T10 at 1 day and Duration time of the sensory block of T10 at 1 day. Planned start Nov 2016; status: withdrawn.
02
Drugs
levobupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01994967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994967.